Elly Savaluny has joined the executive team at Pozen (Nasdaq: POZN) as the pharmaceutical firm’s vice president for biostatistics and data management.
Savaluny will be responsible for data management and statistics analysis of clinical trials to support new drug applications. He worked most recently for Novartis Consumer Health SA as global head of clinical operations, biostatistics and data management.
Pozen: www.Pozen.com
